Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Steroids
|
September 1, 1981
Steroid structural requirements for high affinity binding to human sex steroid binding protein (SBP)
G R Cunningham, D J Tindall, T J Lobl, et al.
The Journal of Biological Chemistry
|
September 25, 1993
A novel cyclic pentapeptide inhibits alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated cell adhesion
D M Nowlin, F Gorcsan, M Moscinski, et al.
Journal of Biochemistry
|
September 1, 1989
Characterization of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma
Y Ishizuka, S Iizumi, F Akiyama, et al.
Contraception
|
April 1, 1983
Contraceptive efficacy of testosterone-estradiol implants in male rhesus monkeys
T J Lobl, K T Kirton, A D Forbes, et al.
The Journal of Biological Chemistry
|
July 15, 1994
Cyclic RGD peptide inhibits alpha 4 beta 1 interaction with connecting segment 1 and vascular cell adhesion molecule
P M Cardarelli, R R Cobb, D M Nowlin, et al.
International Journal of Cancer
|
March 15, 1989
Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents
D R Welch, T J Lobl, E A Seftor, et al.
Cancer Research
|
April 18, 2001
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies
A Trouet, A Passioukov, K Van derpoorten, et al.
FEBS Letters
|
August 4, 1998
Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis
S A Steitz, K Hasegawa, S L Chiang, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity
A M Fernandez, K Van Derpoorten, L Dasnois, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Steroids
|
September 1, 1981
Steroid structural requirements for high affinity binding to human sex steroid binding protein (SBP)
G R Cunningham, D J Tindall, T J Lobl, et al.
The Journal of Biological Chemistry
|
September 25, 1993
A novel cyclic pentapeptide inhibits alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated cell adhesion
D M Nowlin, F Gorcsan, M Moscinski, et al.
Journal of Biochemistry
|
September 1, 1989
Characterization of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma
Y Ishizuka, S Iizumi, F Akiyama, et al.
Contraception
|
April 1, 1983
Contraceptive efficacy of testosterone-estradiol implants in male rhesus monkeys
T J Lobl, K T Kirton, A D Forbes, et al.
The Journal of Biological Chemistry
|
July 15, 1994
Cyclic RGD peptide inhibits alpha 4 beta 1 interaction with connecting segment 1 and vascular cell adhesion molecule
P M Cardarelli, R R Cobb, D M Nowlin, et al.
International Journal of Cancer
|
March 15, 1989
Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents
D R Welch, T J Lobl, E A Seftor, et al.
Cancer Research
|
April 18, 2001
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies
A Trouet, A Passioukov, K Van derpoorten, et al.
FEBS Letters
|
August 4, 1998
Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis
S A Steitz, K Hasegawa, S L Chiang, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity
A M Fernandez, K Van Derpoorten, L Dasnois, et al.
Page
of 3